TY - JOUR ID - 45456 TI - Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Rectum JO - Iranian Journal of Colorectal Research JA - ACRR LA - en SN - AU - Omidvari, Shapour AU - Nasrolahi, Hamid AU - MoaddabShoar, Leila AU - Hamedi, Seyed Hasan AU - Mohammadianpanah, Mohammad AU - Daneshbod, Yahya AU - Ansari, Mansour AU - Ahmadloo, Niloofar AU - Mosalaei, Ahmad AD - Department of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran AD - AD - Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran AD - Dr Daneshbod pathology laboratory, Shiraz, IR Iran AD - Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, IR Iran Y1 - 2013 PY - 2013 VL - 1 IS - 3 SP - 1 EP - 1 KW - Rectum KW - Lymphoma KW - B KW - Cell KW - Marginal Zone KW - Drug therapy KW - Radiotherapy DO - 10.17795/acr-13953 N2 - Introduction Mucosa-associated lymphoid tissue (MALT) lymphoma most commonly involves the stomach and its treatment is surgery, antibiotic therapy or radiotherapy. Rectal MALT is not only so rare but treatment is not as clear as gastric MALT. Case Presentation Our patient was a 66 year-old man presenting with 5-6 months abdominal pain and anemia. In colonoscopy, a rectal ulcer was found and biopsy revealed MALT lymphoma. Physical examination and staging evaluations were normal. Radiotherapy was started for him but he did not tolerate radiotherapy and instead received chemotherapy. After 38 months, he is fine. Conclusions The incidence of rectal MALT is rare and treatment is not so clear. The results on H. pylori eradication, radiotherapy and chemotherapy are more controversial. UR - https://colorectalresearch.sums.ac.ir/article_45456.html L1 - https://colorectalresearch.sums.ac.ir/article_45456_be1da30d8a36a375867bcdf794d814f3.pdf ER -